tiprankstipranks
Astria Therapeutics (ATXS)
NASDAQ:ATXS
US Market

Astria Therapeutics (ATXS) Income Statement

Compare
1,049 Followers

Astria Therapeutics Income Statement

Last quarter (Q3 2024), Astria Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Astria Therapeutics's net income was $-24.53M. See Astria Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -26.00K
Operating Expenses
$ 83.03M$ 53.50M$ 30.36M$ 37.44M$ 27.09M
Depreciation and Amortization
$ -15.20M$ 228.49K$ -164.62M$ 26.00K$ 26.00K
EBITDA
$ -83.03M$ -53.50M$ -194.98M$ -37.44M$ -26.27M
Operating Income
$ -83.03M$ -53.50M$ -194.98M$ -37.44M$ -27.09M
Other Income/Expenses
$ 10.14M$ 1.67M$ 64.00K$ 135.00K$ 795.00K
Pretax Income
$ -72.89M$ -51.83M$ -194.91M$ -37.30M$ -26.29M
Net Income
$ -72.89M$ -50.16M$ -30.17M$ -37.06M$ -26.24M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.42$ -3.43$ -3.38$ -12.12$ -14.06
Diluted EPS
$ -2.42$ -3.43$ -3.38$ -12.12$ -14.06
Weighted Average Shares Outstanding
30.12M 14.62M 8.93M 3.06M 1.87M
Weighted Average Shares Outstanding (Diluted)
30.12M 14.62M 8.93M 3.06M 1.87M
Currency in USD

Astria Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis